HTB homepage • Conference reports • Articles by subject • Subscribe February 2004 Contents Editorial Volume 5 Number 1/2 February/March 2004 Antiretrovirals Abbott raises price of ritonavir in the US by over 400% Development of T-1249 put on hold Tenofovir/abacavir/3TC triple-nuke fails as maintenance regimen New data on viral load ‘blips’ and the link to replication Invirase and Fortovase: new dosing regimens approved by FDA UK named-patient access to tipranavir FDA labelling changes for indinavir (Crixivan) Treatment access Global Fund awards bring total to $2.1bn and supply ARVs to 700,000 people Commentary: The Global Fund and treatment access in Latin America – a critical view Commentary: China starts long march against HIV WHO guidelines for use of ARVs in resource-poor settings Millions will benefit after GSK and BI license generic manufacturers to produce AZT, lamivudine and nevirapine Scaling up treatment access risks damaging national health systems, says WHO/UK report Paediatric care Should treatment be started in all newborns infected with HIV? Tenofovir levels in children approach adult values Study suggests paediatric dose of emtricitabine (FTC) HIV production in children with “undetectable” viral load Host genetic factors are important in disease progression in children Diagnostics US approves 10-minute HIV test Rapid HIV tests offer economic advantages and convenience Use of total lymphocyte count (TLC) for monitoring response to antiretroviral therapy Side effects Importance of dietary management in treating lipid disorders: soy diets may offer comparable effect as statins Weight, diabetes, metabolic complications Human histology and persistence of various injectable filler substances for soft tissue augmentation Coinfections and complications Treating oral hairy leukoplakia with high dose valacyclovir Stem-cell transplants help beat lymphoma Hepatitis coinfection London study finds sexual and intranasal transmission of HCV HCV-coinfection is associated with diabetes and CD4 decline Other news Controversy surrounds British health plans for visitors to the UK Doctors warn of death toll from silent epidemic of hepatitis C On the web WHO guidelines for use of ARVs in resource-poor settings Conferences and guidelines Vaccine research Journal articles available online Online medical lectures Coinfection Newsletters and reports PDFs Volume 5 Number 1/2 February/March 2004 PDF HTB homepage • Conference reports • Articles by subject • Subscribe
